Megakaryon Corporation
Overview
Megakaryon Corporation is a biotechnology firm based in Japan, focusing on the research and development of platelet biopharmaceuticals using innovative stem cell technologies. The company aims to address unmet medical needs related to blood disorders and transfusion medicine through its advanced R&D capabilities.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Megakaryon Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.